title: Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma.
abstract: OBJECTIVE
  To evaluate the prognostic significance of anatomic subsites for marginal zone B cell lymphoma confined to the orbit.
  
  
  METHODS
  From 1995 to 2005, 66 patients (80 lesions) with marginal zone B cell lymphoma, confined to the orbit, received radiation therapy at Samsung Medical Center. The most frequent site of involvement was conjunctiva (29 patients) followed by retrobulbar (20 patients), eyelid (10 patients) and lacrimal gland (7 patients). The median follow-up duration was 50 (13-114) months.
  
  
  RESULTS
  Local relapse developed in two patients, systemic relapse in three, and metachronous relapse in two. The 5-year relapse-free survival rate was 92.0%. A primary tumor located at lacrimal gland was the only poor prognostic factor for relapse (p=0.023, HR=12.263, 95% CI=1.360-110.602). The 5-year actuarial relapse-free survival rate was 57.1% for lacrimal tumor versus 95.8% for non-lacrimal tumors (p=0.002).
  
  
  CONCLUSIONS
  Localized primary orbital MALT lymphomas respond extremely well to moderate-dose RT, with a high local control rate and durable disease free status. However, primary lacrimal involvement maybe related to future relapse more frequently than other orbital subsites.
authors.affiliation: Department of Radiation Oncology, Sungkyunkwan University School of Medicine, Seoul, South Korea.
authors.forename: Heerim
authors.initials: H
authors.lastname: Nam
authors.forename: Yong Chan
authors.initials: YC
authors.lastname: Ahn
authors.forename: Yoon-Duck
authors.initials: YD
authors.lastname: Kim
authors.forename: Younghyeh
authors.initials: Y
authors.lastname: Ko
authors.forename: Won Seog
authors.initials: WS
authors.lastname: Kim
mesh_terms: D000328:Adult; D000368:Aged; D018572:Disease-Free Survival; D005134:Eye Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000473:pathology / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009918:Orbital Neoplasms / Q000473:pathology / Q000532:radiotherapy; D011379:Prognosis; D011832:Radiation Injuries